Industry
Medical - Devices
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
Loading...
Open
1.70
Mkt cap
3.1M
Volume
2.3K
High
1.70
P/E Ratio
-0.06
52-wk high
9.60
Low
1.70
Div yield
N/A
52-wk low
1.37
Portfolio Pulse from Benzinga Newsdesk
August 23, 2024 | 8:38 pm
Portfolio Pulse from Benzinga Newsdesk
August 07, 2024 | 7:21 pm
Portfolio Pulse from Avi Kapoor
August 07, 2024 | 2:38 pm
Portfolio Pulse from Henry Khederian
August 07, 2024 | 2:09 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 9:40 pm
Portfolio Pulse from Benzinga Newsdesk
August 06, 2024 | 9:38 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.